Health2047 spinout leverages community-based approach to tackle prediabetes
With $2 million in seed funding, the company, First Mile Care, is utilizing a coaching and support model in an effort to reverse prediabetes.
Kedalion raises $5M in Series A round for topical eye drug delivery product
Company raises $5 million from Lagunita Biosciences for technology to improve eye drug administration.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Octave Bioscience raises $14 million for MS care management system in Series A round
BCBS Venture Partners leads round, with Section 32, Echo Health Ventures and others participating.
AI researcher from Alphabet’s Calico Labs launches startup applying machine learning to drug discovery
Daphne Zoller, the former chief computing officer of Alphabet's anti-aging business, Calico Labs, also cofounded Coursera in 2012.
Facebook stresses interest in blood donations with new feature
At its F8 conference, the social media giant announced a new capability that enables users in India, Bangladesh and Pakistan to find nearby opportunities to donate blood.
How clinical surveillance is making its mark in healthcare
Hospitals primarily seem to be using their EHRs as clinical surveillance solutions, which seek to pinpoint the early onset of deteriorating conditions in patients, according to a Spyglass Consulting Group report.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The biotech, digital health VC to know
Julie Grant went from associate to partner in a little over three years at Canaan Partners and now wants her understanding of science and corporate America to tame cancer and boost diversity in healthcare.
Facebook hits pause button on research project that asked hospitals to share patient data
CNBC reports the tech giant has halted talks with U.S. hospitals to share anonymized patient information, and Facebook said no data has been shared or analyzed.
Behind Grail, Illumina’s billion-dollar diagnostics startup
With a billion dollars in private financing and a test projected to generate a terabyte of data per person, Grail has seeded a new category of diagnostics and Big Data. Despite this, the company story shared by CEO Jeff Huber is mostly about people.
The decades-long battle for better outcomes in glioblastoma
As many as two-thirds of glioblastoma patients don't respond to a central class of treatments due to a nifty DNA repair mechanism known as MGMT. DelMar Pharmaceuticals has a workaround that it hopes can extend the lives of patients in a meaningful way.
BioLabs Pegasus Park Cultivates Life Science Ecosystem
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
Startup wants to advance minimally invasive device to resolve nasal obstruction
Spirox, based in Menlo Park, California, is traveling down the well-worn path of bringing a minimally invasive approach to complex surgery through a new device.
Samsung, Nestlé teaming up for IoT innovation, but details are scant
The Samsung Strategy and Innovation Center will team up with the Nestlé Institute of Health Sciences to apply wearable sensors and nutritional insights to "provide people with entirely new awareness into health and wellness," the two companies said.
Longitude Capital raises $525M for third fund spanning early to late stage medtech investments
Longitude Founder and Managing Director Marc Galletti said it would begin making investments from the newsest fund starting in the third quarter.
5AM Ventures has raised $285M for fifth fund (Updated)
5 AM Ventures previously raised $250 million in 2013 for 5AM Ventures IV
Canaan, Vivo Capital, Frazier raising $21.3M for stealth infectious disease startup
The three West Coast venture firms are teaming up to build a stealth new startup called Nexcida Therapeutics. They are developing therapeutics for infectious disease, but haven't disclosed anything else.